These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 19477487

  • 21. Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension.
    Nadar SK, Al Yemeni E, Blann AD, Lip GY.
    Thromb Res; 2004; 113(2):123-8. PubMed ID: 15115667
    [Abstract] [Full Text] [Related]

  • 22. Increased pretransplantation plasma kynurenine levels do not protect from but predict acute kidney allograft rejection.
    Lahdou I, Sadeghi M, Daniel V, Schenk M, Renner F, Weimer R, Löb S, Schmidt J, Mehrabi A, Schnitzler P, Königsrainer A, Döhler B, Opelz G, Terness P.
    Hum Immunol; 2010 Nov; 71(11):1067-72. PubMed ID: 20732369
    [Abstract] [Full Text] [Related]

  • 23. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
    Freestone B, Chong AY, Nuttall S, Lip GY.
    Thromb Res; 2008 Nov; 122(1):85-90. PubMed ID: 17996280
    [Abstract] [Full Text] [Related]

  • 24. Oxidative stress - a link between endothelial injury, coagulation activation, and atherosclerosis in haemodialysis patients.
    Pawlak K, Naumnik B, Brzósko S, Pawlak D, Myśliwiec M.
    Am J Nephrol; 2004 Nov; 24(1):154-61. PubMed ID: 14726627
    [Abstract] [Full Text] [Related]

  • 25. Hepatitis intensified oxidative stress, MIP-1beta and RANTES plasma levels in uraemic patients.
    Pawlak K, Pawlak D, Mysliwiec M.
    Cytokine; 2004 Dec 21; 28(6):197-204. PubMed ID: 15566948
    [Abstract] [Full Text] [Related]

  • 26. Oxidative stress effects fibrinolytic system in dialysis uraemic patients.
    Pawlak K, Pawlak D, Mysliwiec M.
    Thromb Res; 2006 Dec 21; 117(5):517-22. PubMed ID: 15964061
    [Abstract] [Full Text] [Related]

  • 27. Haemostatic system, biochemical profiles, kynurenines and the prevalence of cardiovascular disease in peritoneally dialyzed patients.
    Pawlak K, Mysliwiec M, Pawlak D.
    Thromb Res; 2010 Feb 21; 125(2):e40-5. PubMed ID: 19732942
    [Abstract] [Full Text] [Related]

  • 28. Can von Willebrand factor, platelet-endothelial cell adhesion molecule-1 and thrombomodulin be used as alternative markers of endothelial cell injury in human glomerulonephritis?
    Niemir ZI, Kubiak A, Olejniczak P, Nowak A, Czekalski S.
    Rocz Akad Med Bialymst; 2004 Feb 21; 49():213-8. PubMed ID: 15631346
    [Abstract] [Full Text] [Related]

  • 29. Markers for endothelial dysfunction, but not markers for oxidative stress correlate with classical risk factors and the severity of coronary artery disease. (A subgroup analysis from the Ludwigshafen Risk and Cardiovascular Health Study).
    Ruef J, März W, Winkelmann BR.
    Scand Cardiovasc J; 2006 Oct 21; 40(5):274-9. PubMed ID: 17012137
    [Abstract] [Full Text] [Related]

  • 30. Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes.
    Lee KW, Blann AD, Lip GY.
    Int J Cardiol; 2006 Aug 10; 111(2):302-8. PubMed ID: 16324758
    [Abstract] [Full Text] [Related]

  • 31. Biochemical markers of endothelial activation in primary hyperparathyroidism.
    Fallo F, Cella G, Casonato A, Ermani M, Vettor R, Zanella S, Lumachi F.
    Horm Metab Res; 2006 Feb 10; 38(2):125-9. PubMed ID: 16523414
    [Abstract] [Full Text] [Related]

  • 32. Persistent increase in plasma thrombomodulin in patients with a history of lupus nephritis: endothelial cell activation markers.
    Frijns R, Fijnheer R, Schiel A, Donders R, Sixma J, Derksen R.
    J Rheumatol; 2001 Mar 10; 28(3):514-9. PubMed ID: 11296951
    [Abstract] [Full Text] [Related]

  • 33. Short-term high-dose folic acid does not alter markers of endothelial cell damage in patients with coronary heart disease.
    Doshi SN, Moat SJ, Lewis MJ, McDowell IF, Giddings JC, Goodfellow J.
    Int J Cardiol; 2004 Apr 10; 94(2-3):203-7. PubMed ID: 15093982
    [Abstract] [Full Text] [Related]

  • 34. Tryptophan degradation in multiple trauma patients: survivors compared with non-survivors.
    Ploder M, Spittler A, Schroecksnadel K, Neurauter G, Pelinka LE, Roth E, Fuchs D.
    Clin Sci (Lond); 2009 Apr 10; 116(7):593-8. PubMed ID: 18986303
    [Abstract] [Full Text] [Related]

  • 35. Possible association between circulating vascular endothelial growth factor and oxidative stress markers in hemodialysis patients.
    Pawlak K, Pawlak D, Myśliwiec M.
    Med Sci Monit; 2006 Apr 10; 12(4):CR181-5. PubMed ID: 16572054
    [Abstract] [Full Text] [Related]

  • 36. Patient characteristics rather than the type of dialyser predict the variability of endothelial derived surface molecules in chronic haemodialysis patients.
    Grooteman MP, Gritters M, Wauters IM, Schalkwijk CG, Stam F, Twisk J, Ter Wee PM, Nubé MJ.
    Nephrol Dial Transplant; 2005 Dec 10; 20(12):2751-8. PubMed ID: 16188898
    [Abstract] [Full Text] [Related]

  • 37. Thrombomodulin and von Willebrand factor: relation to endothelial dysfunction and disease outcome in children with acute lymphoblastic leukemia.
    Hatzipantelis ES, Athanassiou-Metaxa M, Gombakis N, Tzimouli V, Taparkou A, Sidi-Fragandrea V, Garipidou V, Papageorgiou T, Kleta D, Koliouskas DE, Athanasiadou-Piperopoulou F.
    Acta Haematol; 2011 Dec 10; 125(3):130-5. PubMed ID: 21150180
    [Abstract] [Full Text] [Related]

  • 38. [Molecular markers of endothelial dysfunction in acute ischemic stroke].
    Szegedi N, May Z, Ováry C, Skopál J, Nagy Z.
    Ideggyogy Sz; 2002 Mar 20; 55(3-4):102-8. PubMed ID: 12122979
    [Abstract] [Full Text] [Related]

  • 39. Validity of plasma fibrinogen, D-dimer, and the von Willebrand factor as markers of cardiovascular morbidity in patients on chronic hemodialysis.
    Kirmizis D, Tsiandoulas A, Pangalou M, Koutoupa E, Rozi P, Protopappa M, Barboutis K.
    Med Sci Monit; 2006 Feb 20; 12(2):CR55-62. PubMed ID: 16449948
    [Abstract] [Full Text] [Related]

  • 40. [Effect of oxidative stress in patients with chronic renal failure].
    González Rico M, Puchades MJ, García Ramón R, Saez G, Tormos MC, Miguel A.
    Nefrologia; 2006 Feb 20; 26(2):218-25. PubMed ID: 16808260
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.